Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. (terbuka di window baru)

Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB.

Sumber‎: Ann Intern Med 2008;148(12):939-55.

Index‎: PubMed 18458272

https://www.ncbi.nlm.nih.gov/pubmed/18458272 (terbuka di window baru)

Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. (terbuka di window baru)

Moore RD, Charache S, Terrin ML, Barton FB, Ballas SK.

Sumber‎: Am J Hematol 2000;64(1):26-31.

Index‎: PubMed 10815784

https://www.ncbi.nlm.nih.gov/pubmed/10815784 (terbuka di window baru)

Hydroxyurea for the treatment of sickle cell anemia. (terbuka di window baru)

Platt OS.

Sumber‎: N Engl J Med 2008;358(13):1362-9.

Index‎: PubMed 18367739

DOI‎: 10.1056/NEJMct0708272

https://www.ncbi.nlm.nih.gov/pubmed/18367739 (terbuka di window baru)

Clinical effectiveness of decitabine in severe sickle cell disease. (terbuka di window baru)

Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J.

Sumber‎: Br J Haematol 2008;141(1):126-9.

Index‎: PubMed 18324975

DOI‎: 10.1111/j.1365-2141.2008.07027.x

https://www.ncbi.nlm.nih.gov/pubmed/18324975 (terbuka di window baru)

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). (terbuka di window baru)

Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E.

Sumber‎: Blood 2010;115(12):2354-63.

Index‎: PubMed 19903897

DOI‎: 10.1182/blood-2009-05-221333

https://www.ncbi.nlm.nih.gov/pubmed/19903897 (terbuka di window baru)

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. (terbuka di window baru)

Hirst C, Owusu-Ofori S.

Sumber‎: Cochrane Database Syst Rev 2012;(9):CD003427.

Index‎: PubMed 22972063

DOI‎: 10.1002/14651858.CD003427.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22972063 (terbuka di window baru)

Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial. (terbuka di window baru)

Howard J, Ataga KI, Brown RC, Achebe M, Nduba V, El-Beshlawy A, Hassab H, Agodoa I, Tonda M, Gray S, Lehrer-Graiwer J, Vichinsky E

Sumber‎: Lancet Haematol 2021;8(5):e323-33.

Index‎: PubMed 33838113

DOI‎: 10.1016/S2352-3026(21)00059-4

https://www.ncbi.nlm.nih.gov/pubmed/33838113 (terbuka di window baru)

Sickle cell disease. (terbuka di window baru)

Meremikwu MM, Okomo U.

Sumber‎: BMJ Clin Evid 2011;02:2402.

Index‎: PubMed 21718552

https://www.ncbi.nlm.nih.gov/pubmed/21718552 (terbuka di window baru)

A phase 3 trial of l-glutamine in sickle cell disease. (terbuka di window baru)

Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP

Sumber‎: N Engl J Med 2018;379(3):226-35.

Index‎: PubMed 30021096

DOI‎: 10.1056/NEJMoa1715971

https://www.ncbi.nlm.nih.gov/pubmed/30021096 (terbuka di window baru)

Malaria chemoprophylaxis in sickle cell disease. (terbuka di window baru)

Oniyangi O, Omari AA.

Sumber‎: Cochrane Database Syst Rev 2006;(4):CD003489.

Index‎: PubMed 17054173

DOI‎: 10.1002/14651858.CD003489.pub2

https://www.ncbi.nlm.nih.gov/pubmed/17054173 (terbuka di window baru)